SCHEMBL1053407

SCHEMBL1053407

C[C@@H](O)C1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18707170 1.00 TP53 (0.46)
SCHEMBL1056494 1.00
SCHEMBL6663981 1.00 TP53 (0.46)
SCHEMBL5195 1.00
SCHEMBL8086336 1.00 TP53 (0.46)
SCHEMBL18706728 1.00 TP53 (0.46)
SCHEMBL11165174 1.00 TP53 (0.46)
SCHEMBL4731258 1.00 TP53 (0.46)
SCHEMBL8008434 0.97 TP53 (0.44)
Ammonia Solution, Strong SCHEMBL11270348 0.97 TP53 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4084620-B1 USE OF A STARCH MIXTURE IN A DAIRY PRODUCT ROQUETTE FRERES (FR) 2026-03-11 EP disclosed
EP-4688741-A1 COMPOUNDS FOR TREATING FIBROTIC DISEASES Meta-Immune, Inc. (KR) 2026-02-11 EP disclosed
US-20250129067-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2025-04-24 US disclosed
WO-2025064224-A1 RICE-BASED GELLING SYSTEMS IN FOOD APPLICATIONS CARGILL, INCORPORATED (US) 2025-03-27 WO disclosed
WO-2024249867-A1 COMPOUNDS FOR TREATING FIBROTIC DISEASES AM SCIENCES (KR) 2024-12-05 WO disclosed
EP-4430047-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2024-09-18 EP disclosed
CN-118475580-A Platelet-derived growth factor receptor (PDGFR) alpha inhibitors and uses thereof 普罗根托斯治疗公司 2024-08-09 CN disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
US-20230303599-A1 PRODRUGS OF PHOSPHONAMIDE NUCLEOTIDE ANALOGUES AND THEIR PHARMACEUTICAL USE GILEAD SCIENCES, INC. 2023-09-28 US disclosed
US-20230303599-A1 PRODRUGS OF PHOSPHONAMIDE NUCLEOTIDE ANALOGUES AND THEIR PHARMACEUTICAL USE GILEAD SCIENCES, INC. 2023-09-28 US disclosed
US-20090048227-A1 Substituted-1-Phthalazinamines As Vr- 1 Antagonists MERCK SHARP & DOHME CORP. 2009-02-19 US disclosed
US-20080064736-A1 Substituted 2-Pyrrolidone Derivatives as Fungicides and Insecticides BAYER CROPSCIENCE AG (DE) 2008-03-13 US disclosed
WO-2007065662-A2 TRISUBSTITUTED QUINAZOLINONE DERIVATIVES AS VANILLOID ANTAGONISTS NOVARTIS AG (CH) 2007-06-14 WO disclosed
EP-1485471-A1 ALCOHOL DEHYDROGENASES WITH HIGH SOLVENT AND TEMPERATURE STABILITY Ciba SC Holding AG (CH) 2004-12-15 EP disclosed
WO-2003078615-A1 ALCOHOL DEHYDROGENASES WITH HIGH SOLVENT AND TEMPERATURE STABILITY CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-09-25 WO disclosed
WO-2003068233-A1 NICOTINAMIDE DERIVATIVES AND A TIOTROPIUM SALT IN COMBINATION FOR THE TREATMENT OF E.G. INFLAMMATORY, ALLERGIC AND RESPIRATORY DISEASES PFIZER LIMITED (GB) 2003-08-21 WO disclosed
WO-2003068235-A1 NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS PFIZER LIMITED (GB) 2003-08-21 WO disclosed
US-5552548-A Enantioselective oxazaborolidine catalysts PFIZER INC. (US) 1996-09-03 US disclosed
EP-0268388-B1 ANTI-INFLAMMATORY COMPOSITIONS GLAXO GROUP LIMITED (GB) 1992-07-22 EP disclosed
US-5096971-A Acrylic graft copolymer MITSUBISHI KASEI CORPORATION (JP) 1992-03-17 US disclosed